Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_3696
http://purl.obolibrary.org/obo/CHEBI_3696
|
|---|---|
| Preferred Name | cidofovir anhydrous |
| Synonyms |
C8H14N3O6P
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-HPMPC
cidofovir
Cidofovir
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
(S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
CDV
(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
Cidofovir anhydrous
({[(2S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | cidofovir anhydrous
|
|---|---|
| label | cidofovir anhydrous
|
| DBSynonym |
cdv
cidofovir anhydrous
|
| ATCCode | J05AB12
|
| Definition | Cytosine substituted at the 1 position by a 3-hydroxy-2-(phosphonomethoxy)propyl group (S configuration). A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.
|
| altId |
CHEBI:148701
CHEBI:666483
|
| has pharmacological target | |
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=VWFCHDSQECPREK-LURJTMIESA-N
|
| Synonym |
C8H14N3O6P
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-HPMPC
cidofovir
Cidofovir
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
(S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
CDV
(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
Cidofovir anhydrous
({[(2S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
See more
See less
|
| xref |
CASRN:113852-37-2
Patent:EP253412
Drugs.com:http://www.drugs.com/cdi/cidofovir.html
DrugBank:DB00369
Patent:US5142051
PubChem Substance:46506054
RxList:http://www.rxlist.com/cgi/generic2/cidofovir.htm
BindingDB:31915
PubChem Compound:60613
Beilstein:5080484
Wikipedia:http://en.wikipedia.org/wiki/Cidofovir
ChemSpider:54636
PharmGKB:PA448997
Wikipedia:Cidofovir
National Drug Code Directory:61958-0101-1
KEGG COMPOUND:C06909
ChEBI:3696
See more
See less
|
| CASRN | 113852-37-2
|
| prefixIRI | obo2:CHEBI_3696
|
| is transported by | |
| SMILES |
NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1
|
| DBname | cidofovir
|
| InChI | InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
|
| DBBrand |
vistide
hpmpc
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |